“t-cell” Archives

in
Entry Author Date Location
ASCO 2019: The Long Game, Targeted Pills, First-Ever Buzz & More 06/05/19 National
For CAR-T Cancer Fighters in the Real World, Two Roads Diverge 01/03/19 National
Drug Developer Kiromic Declines San Antonio’s Cash Offer for HQ Move 07/17/18 Texas
Eying Clinical Trials, Shattuck Labs Adds $46M for Immunotherapy R&D 05/30/18 Texas
Immunotherapy Biotech Kiromic Considers San Antonio Move for Cash 05/24/18 Texas
Ex-Kite Execs Resurface with $300M and Control of Pfizer CAR-T Cells 04/03/18 San Francisco
Bellicum Reveals Brain Injuries, FDA Halt on Lead T-Cell Product 01/31/18 Texas
Bio Roundup: Spark v. ICER, A Solid Revelation, T Cell Deals & More 01/26/18 National
Kite Nabs First Adult CAR-T Approval With Notable Uptick Of Cures 10/18/17 National
Palleon Lands $48M to Develop New Type of Checkpoint Cancer Drug 10/04/17 Boston
Novartis Wins Historic FDA Nod, Prices CAR-T For Leukemia at $475,000 08/30/17 National
Acer Therapeutics Announces Reverse Merger With Houston’s Opexa 07/05/17 Texas
ASH Roundup: CAR-T Shuffle, Hemophilia Updates, Checkpoint Progress & More 12/06/16 National
Two More Deaths In Trial Halt Juno’s Top CAR-T Treatment Again 11/23/16 Seattle
All In One Place: A New Immuno-Oncology Trial Resource 10/19/16 National
Novartis Disbands T Cell Group But Promises To Press Ahead In CAR-T Race 08/31/16 National
War, Surgery, and Cancer Vaccines: Meet San Antonio’s George Peoples 08/19/16 Texas
With New Name and $86M, Tioma To Explore Anti-CD47 Cancer Therapy 08/16/16 San Francisco
With Celgene Deal, Jounce Lands $261M And a “Trusting Partner” 07/19/16 Boston
West Coast Bio Roundup: UCLA Cashes In, BioMarin Tries Again & More 03/04/16 San Francisco
JLabs @ TMC Opens Houston Campus, Home to 21 Biotech Startups 03/02/16 Texas
Bayer, CRISPR Therapeutics Form $335M+ Gene Editing Venture 12/21/15 Boston
What Three Biotechs Could Tell Us About The Pfizer-Allergan Merger 12/01/15 National
Small Molecules: The Silent Majority of Pharmaceutical Pipelines 11/23/15 Boston
With Termeer Aboard, Artax Tries New Attack On Autoimmune Disease 09/22/15 Boston
Reality Check: Cancer Experts Discuss Hurdles Facing CAR-T Therapy 09/18/15 National
With New Tools, Adaptive Bio Ready To Bolt Together A Drug Business 08/20/15 Seattle
East Coast Biotech Roundup: Biogen, Epizyme, Armored CARS, & More 07/13/15 Boston
After Celgene Deal, Juno Revs Armored CAR For Ovarian Cancer Trial 07/10/15 Seattle
West Coast Biotech Roundup: Juno, UCSD v. USC, Natera, LSDF & More 07/06/15 Seattle
Page 1 of 2 next page »